Phase 2 Clinical Trial of PC(Procarbazine-CCNU) Chemotherapy in Patients With Recurrent or Resistant Glioblastoma With Methylated MGMT
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lomustine (Primary) ; Procarbazine (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 16 Jan 2013 Planned end date changed from 1 Apr 2014 to 30 Apr 2014 as reported by Korean Clinical Trials Register.
- 16 Jan 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000605).
- 07 Jan 2013 New trial record